The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to Risk Sciences International Inc. to provide operations, maintenance, and feature development services for the FDA-iRISK system. The single award IDV has a potential value of $1.3 million and a period of performance through September 2025.
Under the IDV, Risk Sciences has received multiple delivery orders to host and maintain existing versions of FDA-iRISK, as well as develop new features. Tasks have included hosting versions 4.0P through 4.4I of the software platform from 2020 through 2024 at prices ranging from $135,325 to $350,670. Risk Sciences has performed services under the orders in the United States and Canada. No set-asides were applied to the IDV or its orders.
The FDA utilizes the FDA-iRISK system to support its risk-based regulatory activities. The IDV and its orders aim to provide ongoing operations and maintenance of the existing software, along with new capabilities, to ensure the agency can continue leveraging the system's risk assessment functions. Risk Sciences' work under this vehicle assists the FDA in maintaining its risk management programs through technical support for the information technology solution.
Generated 1/5/24, 1:20 AM